Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Telangiectasis

• To Evaluate the Effects of EryDex in Patients With A-T
• Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)
• Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects
• Assess Safety and Efficacy of VAD044 in HHT Patients
• Sirolimus for Nosebleeds in HHT
• Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
• Serine and Fenofibrate Study in Patients With MacTel Type 2
• MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia
• NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
• Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
• Bevacizumab In Hereditary Hemorrhagic Telangiectasia
• Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
• Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients
• Vitamin D and Hereditary Haemorrhagic Telangiectasia
• Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.
• Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease
• Pomalidomide for the Treatment of Bleeding in HHT
• Pazopanib Effects on Bleeding in Hereditary Hemorrhagic Telangiectasia
• Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
• Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1
• N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
• A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)
• Doxycycline for Hereditary Hemorrhagic Telangiectasia
• BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hereditary Telangiectasia (HHT).
• Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)
• Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
• Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
• EDS in Ataxia Telangiectasia Patients
• Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias
• Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
• Polidocanol Versus Glucose Treatment of Telangiectasia Trial
• Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
• Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)
• Intranasal Bevacizumab for HHT-Related Epistaxis
• Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
• Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
• Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
• Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
• Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
• Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
• The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
• Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
• Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
• North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
• Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
• Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
• Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
• The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)
• Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
• High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
• Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
• Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
• Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
• Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
• Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth
• Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth
• Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
• Baclofen Treatment of Ataxia Telangiectasia
• Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia
• Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)
• Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
• Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
• Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
• Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
• Effect of Avastin in Juxtafoveal Telangiectasias
• Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
• Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
• Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
• ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome
• Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).
• Study for Treatment of Cancer in Children With Ataxia-telangiectasia
• Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
• Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia